| 
 | Compound Information | SONAR Target prediction |  | Name: | beta-SITOSTEROL |  | Unique Identifier: | SPE00107022 |  | MolClass: | Checkout models in ver1.5 and ver1.0 |  | Molecular Formula: |  |  | Molecular Weight: | 364.31 g/mol |  | X log p: | 3.299  (online calculus) |  | Lipinksi Failures | 0 |  | TPSA | 0 |  | Hydrogen Bond Donor Count: | 0 |  | Hydrogen Bond Acceptors Count: | 1 |  | Rotatable Bond Count: | 6 |  | Canonical Smiles: | CCC(CCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C |  | Class: | sterol |  | Source: | widespread in plants |  | Reference: | J Am Chem Soc 48: 2987 (1926) |  | Generic_name: | CHOLESTEROL |  | Chemical_iupac_name: | CHOLESTEROL |  | Drug_type: | Experimental |  | Kegg_compound_id: | C00187 |  | Drugbank_id: | EXPT00945 |  | Logp: | 7.445 |  | Cas_registry_number: | 57-88-5 |  | Drug_category: | Nuclear Receptor Ror-Alpha inhibitor |  | Organisms_affected: | -1 | 
 
 
	
		| Species: | 4932 |  
		| Condition: | CLN2 |  
		| Replicates: | 2 |  
		| Raw OD Value: r im | 0.6585±0.0170413 |  
		| Normalized OD Score: sc h | 0.9681±0.0182804 |  
		| Z-Score: | -2.3654±0.698456 |  
		| p-Value: | 0.0327592 |  
		| Z-Factor: | -18.717 |  
		| Fitness Defect: | 3.4186 |  
		| Bioactivity Statement: | Nonactive |  | | Experimental Conditions |  |  | Library: | Spectrum_ED |  | Plate Number and Position: | 16|C4 |  | Drug Concentration: | 50.00 nM |  | OD Absorbance: | 595 nm |  | Robot Temperature: | 30.00 Celcius |  | Date: | 2010-08-10 YYYY-MM-DD |  | Plate CH Control (+): | 0.09399999999999999±0.00770 |  | Plate DMSO Control (-): | 0.8842499999999999±0.02685 |  | Plate Z-Factor: | 0.8669 | 
 |  png ps
 pdf
 | 
 
 
	
		| 304 | 10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenan thren-3-ol
 |  
		| 5997 | (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-do decahydro-1H-cyclopenta[a]phenanthren-3-ol
 |  
		| 6744 | (3S,8S,9S,10R,13R,14S,17R)-17-[(2S,5S)-5-ethyl-6-methyl-heptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14 ,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
 |  
		| 6745 | (3S)-17-[(5S)-5-ethyl-6-methyl-heptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H- cyclopenta[a]phenanthren-3-ol
 |  
		| 6746 | (3S,8S,9S,10R,13R,14S,17R)-17-[(2S,5S)-5-ethyl-6-methyl-hept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12 ,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
 |  
		| 9401 | (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-(6-methylhept-5-en-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dode cahydro-1H-cyclopenta[a]phenanthren-3-ol
 |  
 | internal high similarity DBLink  | Rows returned: 8 | << Back 1 2 | 
 
 | active | Cluster 17506 | Additional Members: 20 | Rows returned: 4 |  | 
 
 |